novel drug delivery systems
TRANSCRIPT
Novel Drug Delivery Systems
Dr.Maulik M PatelAssistant Professor
Aims for new drug delivery systems
Selective targeting of drugs to the site of acton
Try to make “ideal” drugs
increase the bioavailability. provide controlled delivery of drug transport the drugs intact to the site of action
avoiding the non diseased tissue
stable and delivery be maintained under various physiological variables.
easy to administer , safe and reliable
cost effective
Characteristics of ideal DDS
Medical-optimum dose , at the right time and at the right location
Industrial-Efficient use of expensive ingredients, reduction in production cost
Social-Beneficial to patients, better therapy, improved compliance and standard of living
Benefits
Modified-release drug formulations-Sustained and Controlled PolymersMicellesLiposomesEthosomesNenotechnology
ProdrugsTransdermal Drug delivery systemsOcusertInsulin jet and Micro pump controlled delivery systemPatient controlled analgesia(PCA)Drug eluting stentsGene therapyPersonalised medicine
Novel Drug delivery systems
Modified-release Drug
formulations
A way of formulating a medicine so that it is released into the body steadily, over a long period of time, Increases duration of action of a drug Reducing dosing frequency Once-daily oral preparations Long lasting depot injections(e.g.
contraceptives, hormone replacements, antipsychotic drugs)
Sustained Release drug formulations
Water
Hydratable dry polymer
Drug Drug
Dry polymer containing immobile drug
Hydratable gel containingDiffusible drug
It closely mimics the way by which the body naturally produces hormones such as insulin.
A way of formulating the medicine so it is released into the body in respond to specific stimuli e.g.
Exposure to light, Changes in pH or temperature.
Controlled Release drug formulations
Disintegrate when temperature is increased
Local heating of a tumour will cause the drug to be released at that site
Temperature sensitive liposomes
Used to delay the release of acid sensitive drugs( Peptides)
Drug delivery targeted to regions of low pH ,
Such as inflamed or hypoxic tissues
pH sensitive polymers
12
pH Sensitive CR Formulation
Pharmaceutical Polymers
Biodegradability and biocompatibility
Biodegradation is generally described by two steps, (1) water penetrates polymeric matrix, attacking the chemical bonds by hydrolysis and metabolism of the fragments (2) surface erosion of the polymer
Biocompatibility refers to specific properties of a material not having toxic or injurious effects on biological systems.
Consist of aggregates of a few hundred amphiphilic molecules
That contains distinct Hydrophilic regions facing the surrounding water And Hydrophobic regions forming an inner core.
Micelles
Typically have diameter of 10-80 nm, Small enough not to sediment under gravity
But large enough –Can’t cross tight capillary endothelium (BBB)
Malignant tumors and inflamed tissues have large fenestrated capillaries, so transfer into such tissues more rapid than normal tissues
Absorption directly to the lymphatic system rather than vascular system to bypass first pass metabolism
Protect the drug from metabolic degradation, so half life is prolonged
Advantages of Micelles
First discovered in 1965 and proposed as drug carriers afterwards
Microscopic vesicles formed when an aqueous suspension of phospholipid is exposed to ultrasonic agitation
Large multilayered vesicles or small single layered vesicles may be formed.
Liposomes
Cholesterol/Phospholipid bilayer
Polymer coat(PEG)
TargettingMolecules(Antibody)
Drug substance
Liposome
Ethosomes are the slight modification of well established drug carrier- liposome.
Ethosomes are lipid vesicles containing phospholipids with high concentrations of ethanol and water.
These are vesicles tailored for enhanced delivery of active agents
Ethosomes
Ethanol causes skin disruption ↓
More permeability through skin ↓
Ethosomes permeate inside ↓
Fuse with skin lipids ↓
Release drug into deep skin layers
Mechanism of Action
Nanotechnology is the technology useful for synthesis of materials, devices and system by controlling shape and size at nanometer scale, (1-100 nm).
Achievements: -once daily oral Ciprofloxacin -tumor targeted delivery -improved ophthalmic delivery -oral insulin -oral administration of other peptides
Nanotechnology based DDS
Prodrugs
Transdermal DDSActive ingredient is delivered across the skin for systemic distribution.Example: transderm scopolamine, nitroglycerine , nicotine, Fentanyl
Avoid the risk and inconveniences associated with parenteral/ oral routes.
Increase the bioavailability - bypassing hepatic first pass metabolism
Bypass the variation in absorption and metabolism.
continuous drug administration Reduce the chance of over or under dosing
Advantages of transdermal DDS
31
Ocular Insert- Occusertto increase the contact time between the preparation and the conjunctival tissue to ensure a sustained release suited to topical or systemic treatment.
Delivers insulin subcutaneously without using needle Achieved by pressurizing the liquid through a small
orifice which creates high speed jet that can penetrate the skin and underlying tissue.
Insulin jet
It is a computerized syringe which delivers insulin into the subcutaneous tissue every few minutes in tiny amount 24 hours a day through a canula placed in the subcutaneous tissue.
Micro pump insulin delivery system
Patient can control the release of analgesic drug depending on the pain – this can be useful in cancer pain
Patient Controlled Analgesia
Genetic Transfer System Under evaluation & III Phase clinical trials
for Adenovirus & HIV
means prescription of specific treatment and therapeutics best suited for an individual. It is also referred to as individualized or individual based therapy based on the patient genotype, circadian rhythm, biochemical and hematological parameters.
Example: Isoniazid , Sch , G-6 PD, p-glycoprotein ,Malignant hyperthermia by halothane
Personalized medicine-ultimate goal of new DDS